Studies, Surveys, Papers, and Case Studies

Sometimes it's necessary to view the PDF version to access the full study.
This page is for referencing the possible benefits of Non-Tobacco Products (not NRT) vs. smoking cigarettes.
If you'd prefer someone else to add a study to a topic, there is a subject section called "Suggested studies to add to this page". You may put the link in that section for one of the regular page editors to address.
PAGE EDITORS - Please only add Studies, Surveys, Papers in this format to keep page consistent for all viewers.
- Topic
- Year (list new to old) Name of Study (In link format to the study)
- Note here if animal study (leave blank if not)
- Brief Summary
- Link to PDF Version
- Citation
- Acknowledgements (funded by, helped by)
- Keywords
- Other

HELP WANTED: We are looking for a volunteer to research the possible THR benefits of Non-Tobacco Products (not NRT) and enter them on this page

Lozenges

Pouches

Compares cost in various countries to other forms of tobacco Harm Reduction Products.
There is a significant role for nicotine pouches in tobacco harm reduction in Emerging Markets, particularly in countries where oral tobacco use is prevalent.
In theory, regulators should look more favourably on the category, but this has not proven to be the case. In part, the industry needs to take a more proactive approach and engage with regulators and local stakeholders, where appropriate, before launching new products.
Nicotine pouches don't require consumers to buy often prohibitively expensive devices. Still, relatively high current production costs make it challenging to earn the returns needed to facilitate meaningful investment in many developing countries. Over time, this could be addressed by a combination of appropriate excise-tax regimes and reduced input costs.

Nonusers of tobacco had very little interest in ZYN. Smokeless tobacco users are not only more interested and likely to buy ZYN than other tobacco users, they were the largest group of regular users.
The first assessment of a new nicotine product, ZYN, suggests that current and former tobacco users may perceive ZYN as a reduced‐risk product. ZYN potentially could be used as a smoking/tobacco‐cessation aid based on reasons of current users.
PDF Version
Citation: Plurphanswat, N., Hughes, J. R., Fagerström, K., & Rodu, B. (2020). Initial Information on a Novel Nicotine Product. The American Journal on Addictions. doi:10.1111/ajad.13020
Brad Rodu’s Blog: First Study of ZYN, A Novel Consumer Nicotine Product

Click on the category link below for more studies by topic on Smokeless Tobacco and Nicotine.